Cargando…
Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment
Circulating osteogenic precursor (COP) cells are peripheral blood cells with a capacity for osteogenesis. The objective of our study was to ascertain the percentage of COPs as an early biomarker of osteoporosis and the effect of these cells in response to Denosumab (DmAb) (anti-resorptive) or to Ter...
Autores principales: | Giner, Mercè, Vázquez-Gámez, María Angeles, Miranda, María José, Bocio-Nuñez, Jesús, Olmo-Montes, Francisco Jesús, Rico, Miguel Angel, Colmenero, Miguel Angel, Montoya-García, María-José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409740/ https://www.ncbi.nlm.nih.gov/pubmed/36012987 http://dx.doi.org/10.3390/jcm11164749 |
Ejemplares similares
-
Fragility Fractures and Imminent Fracture Risk in the Spanish Population: A Retrospective Observational Cohort Study
por: Montoya-García, Maria-José, et al.
Publicado: (2021) -
The Fracture Liaison Service of the Virgen Macarena University Hospital Reduces the Gap in the Management of Osteoporosis, Particularly in Men. It Meets the International Osteoporosis Foundation Quality Standards
por: Olmo-Montes, Francisco-Jesús, et al.
Publicado: (2021) -
Effect of Denosumab and Teriparatide on Fracture Nonunion
por: Boutin, Regine, et al.
Publicado: (2023) -
Differences in osteogenic and apoptotic genes between osteoporotic and osteoarthritic patients
por: Giner, Mercè, et al.
Publicado: (2013) -
Incidence, morbidity and mortality of hip fractures over a period of 20 years in a health area of Southern Spain
por: Rey-Rodriguez, Marta M, et al.
Publicado: (2020)